Profile: Super Gen, Inc. focuses on pharmaceutical products related to cancer. CLIMB™ is our approach to small molecule drug discovery, which merges rapid screening of compound libraries with computational chemistry and systems biology techniques to identify drug leads that bind to target proteins. It is an iterative and evolving process, incorporating techniques from computational design to laboratory bench biology & chemistry, to yield targeted therapeutics for use in the clinic. Our development pipeline comprises of several promising compound classes at various stages of development with good drug like properties, ensuring a steady flow of novel therapeutics into the clinic.